-
29109-5An analytical reference standard that is structurally similar to known phytocannabinoids intended for research and forensic applications
-
13172-10HDAC1 and HDAC3 inhibitor (ID50 = 0.01 and 0.07 &muM, respectively, in vitro) induces apoptosis in nine different neuroblastoma cell lines in culture (0.5-4.0 &muM) and completely suppresses neuroblastoma tumor growth in SCID mice at 200 mg/kg.
-
13172-25HDAC1 and HDAC3 inhibitor (ID50 = 0.01 and 0.07 &muM, respectively, in vitro) induces apoptosis in nine different neuroblastoma cell lines in culture (0.5-4.0 &muM) and completely suppresses neuroblastoma tumor growth in SCID mice at 200 mg/kg.
-
13172-5HDAC1 and HDAC3 inhibitor (ID50 = 0.01 and 0.07 &muM, respectively, in vitro) induces apoptosis in nine different neuroblastoma cell lines in culture (0.5-4.0 &muM) and completely suppresses neuroblastoma tumor growth in SCID mice at 200 mg/kg.
-
19373-1A water soluble and metabolically stable curaxin that activates p53 with an EC<sub>50</sub> value of 0.37 µM and inhibits NF-&kappaB with an EC<sub>50</sub> value of 0.
-
19373-10A water soluble and metabolically stable curaxin that activates p53 with an EC<sub>50</sub> value of 0.37 µM and inhibits NF-&kappaB with an EC<sub>50</sub> value of 0.
-
19373-5A water soluble and metabolically stable curaxin that activates p53 with an EC<sub>50</sub> value of 0.37 µM and inhibits NF-&kappaB with an EC<sub>50</sub> value of 0.
-
19110-1A water soluble and metabolically stable curaxin that activates p53 with an EC<sub>50</sub> value of 0.37 µM and inhibits NF-&kappaB with an EC<sub>50</sub> of 0.47 µM has broad anticancer activity in mice when administered orally.
-
19110-10A water soluble and metabolically stable curaxin that activates p53 with an EC<sub>50</sub> value of 0.37 µM and inhibits NF-&kappaB with an EC<sub>50</sub> of 0.47 µM has broad anticancer activity in mice when administered orally.
-
19110-5A water soluble and metabolically stable curaxin that activates p53 with an EC<sub>50</sub> value of 0.37 µM and inhibits NF-&kappaB with an EC<sub>50</sub> of 0.47 µM has broad anticancer activity in mice when administered orally.
-
A01798-40CBP affinity tag is a useful tag in protein study which can be added to the N or C terminus of proteins of interest through DNA recombinant technology. The tag is derived from muscle myosin light-chain kinase.
-
A00635-40CBP tag is a calmodulin-binding peptide, KRRWKKNFIAVSAANRFKKISSSGAL, derived from skeletal/cardiac muscle myosin light chain kinase 2. GenScript Rabbit Anti-CBP-tag Polyclonal Antibody is developed in rabbit hosts using a synthetic CBP tag peptide